JOYY Inc. (NASDAQ: YY) ("JOYY" or the "Company"), a global leading technology company, announced its unaudited financial results for the third quarter of 2024. SINGAPORE, Nov. 27, 2024 (GLOBE ...

We therefore tested whether antigen secretion is essential for eliciting ESAT-6-specific T-cell responses ... proliferation assays in response to in vitro stimulation with a peptide from Mal ...

Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice.

Feb. 18, 2025 — Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication ...